首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2556篇
  免费   255篇
  国内免费   269篇
  2024年   10篇
  2023年   31篇
  2022年   68篇
  2021年   123篇
  2020年   79篇
  2019年   99篇
  2018年   75篇
  2017年   72篇
  2016年   108篇
  2015年   152篇
  2014年   172篇
  2013年   177篇
  2012年   188篇
  2011年   193篇
  2010年   133篇
  2009年   117篇
  2008年   138篇
  2007年   146篇
  2006年   131篇
  2005年   109篇
  2004年   91篇
  2003年   88篇
  2002年   77篇
  2001年   32篇
  2000年   36篇
  1999年   40篇
  1998年   22篇
  1997年   28篇
  1996年   16篇
  1995年   14篇
  1994年   16篇
  1993年   16篇
  1992年   24篇
  1991年   22篇
  1990年   23篇
  1989年   29篇
  1988年   29篇
  1987年   16篇
  1986年   16篇
  1985年   12篇
  1984年   17篇
  1983年   11篇
  1982年   10篇
  1981年   9篇
  1980年   7篇
  1979年   10篇
  1978年   7篇
  1977年   6篇
  1976年   7篇
  1973年   7篇
排序方式: 共有3080条查询结果,搜索用时 15 毫秒
111.
112.
Genome editing with engineered nucleases (GEEN) represents a highly specific and efficient tool for crop improvement with the potential to rapidly generate useful novel phenotypes/traits. Genome editing techniques initiate specifically targeted double strand breaks facilitating DNA‐repair pathways that lead to base additions or deletions by non‐homologous end joining as well as targeted gene replacements or transgene insertions involving homology‐directed repair mechanisms. Many of these techniques and the ancillary processes they employ generate phenotypic variation that is indistinguishable from that obtained through natural means or conventional mutagenesis; and therefore, they do not readily fit current definitions of genetically engineered or genetically modified used within most regulatory regimes. Addressing ambiguities regarding the regulatory status of genome editing techniques is critical to their application for development of economically useful crop traits. Continued regulatory focus on the process used, rather than the nature of the novel phenotype developed, results in confusion on the part of regulators, product developers, and the public alike and creates uncertainty as of the use of genome engineering tools for crop improvement.  相似文献   
113.
Age‐related cataract is among the most common chronic disorders of ageing and is the world's leading blinding disorder. Long non‐coding RNAs play important roles in several biological processes and complicated diseases. However, the role of lncRNAs in the setting of cataract is still unknown. Here, we extracted total RNAs from the transparent and age‐matched cataractous human lenses, and determined lncRNA expression profiles using microarray analysis. We found that 38 lncRNAs were differentially expressed between transparent and cataractous lenses. 17 of 20 differentially expressed lncRNAs were further verified by quantitative RT‐PCRs. One top abundant lncRNA, MIAT, was specifically up‐regulated both in the plasma fraction of whole blood and aqueous humor of cataract patients. MIAT knockdown could affect the proliferation, apoptosis and migration of Human lens epithelial cells (HLECs) upon oxidative stress. Posterior capsule opacification (PCO) is a common complication of cataract surgery, which is associated with abnormal production of inflammatory factors. MIAT knockdown could repress tumour necrosis factor‐α‐induced abnormal proliferation and migration of HLECs, suggesting a potential role of MIAT in PCO‐related pathological process. Moreover, we found that MIAT acted as a ceRNA, and formed a feedback loop with Akt and miR‐150‐5p to regulate HLEC function. Collectively, this study provides a novel insight into the pathogenesis of age‐related cataract.  相似文献   
114.
银屑病是一种慢性易复发的炎性皮肤疾病,为了探讨新型小分子化合物FMS样的酪氨酸激酶3(fms-like tyrosine kinase 3,FLT3)抑制剂对银屑病的治疗作用,采用了小鼠尾部鳞片表皮颗粒层形成模型,分别进行口服及外用给药,并取尾部皮肤制作病理切片,计算有颗粒层形成的鳞片数。结果显示:口服给药及外用给药组小鼠尾部鳞片颗粒细胞数均显著高于空白对照组(P0.01),同时实验组小鼠颗粒细胞体积增大,胞浆内颗粒粗大且染色较深,细胞分界清楚,细胞核及核仁明显,但是各实验组内不同浓度间差异不显著,此外口服给药及外用给药组小鼠内脏器官均未出现明显的毒副作用。以上结果说明该新型小分子化合物FLT3抑制剂能使小鼠尾部鳞片颗粒细胞显著增多,而且口服和外用制剂均能有效拮抗银屑病,并对小鼠内脏器官无明显的毒副作用。  相似文献   
115.
116.
目的:急性缺血性脑卒中(Acute ischemic stroke, AIS)是由于血流减少导致的脑功能突然丧失。由于AIS发病机制是异质性和多因素的,我们建立全面的脂质组学方法来阐明AIS进程相关的脂质变化和复杂的脂质代谢网络。方法:选取26例AIS患者血液标本和27例健康志愿者血清作为研究对象,进行总脂抽提,通过基于LC-MS策略的非靶向脂质组学方法进行规模性、整体性的脂质组学分析。结果:对AIS患者和健康志愿者血浆进行大规模脂质定性定量分析,通过Progenesis~? QI软件分析Xevo~? G2-XS QTOF质谱系统MSE采集的子离子数据,精确定量到1054个脂质特征差异,准确定性得到368个脂质分子,多变量统计分析中差异脂质组成能将AIS患者和健康志愿者区分开来,通路富集分析图显示差异脂质主要参与甘油磷脂代谢的紊乱。结论:AIS患者血浆脂质组成与健康志愿者存在显著差异,差异表达的脂质可能与AIS发生有关。这些发现有助于开发新的诊断标志物和AIS治疗靶点。  相似文献   
117.
Lung cancer (LC) is a devastating malignancy with no effective treatments, due to its complex genomic profile. Using bioinformatics analysis and immunohistochemical of lung carcinoma tissues, we show that TRIM59 as a critical oncoprotein relating to LC proliferation and metastasis. In this study, high TRIM59 expression was significantly correlated with lymph node metastasis, distant metastasis, and tumour stage. Furthermore, up‐regulation of TRIM59 expression correlated with poorer outcomes in LC patients. Mechanistically, TRIM59 play a key role in promoting LC growth and metastasis through regulation of extracellular‐signal regulated protein kinase (ERK) signalling pathway and epithelial‐to‐mesenchymal transition (EMT)‐markers, as validated by loss‐of‐function studies. In‐depth bioinformatics analysis showed that there is preliminary evidence of co‐expression of TRIM59 and cyclin dependent kinase 6 (CDK6) in LC. Notably, CDK6 expression significantly decreased when TRIM59 was knocked down in the LC cells. In contrast, exogenous up‐regulation of TRIM59 expression also induced significant increases in the expression of CDK6. Moreover, the expression of CDK6 was also inhibited by the ERK signalling inhibitor, U0126. The results of both loss‐ and gain‐of‐function studies showed that TRIM59 could regulate the expression of CDK6. Collectively, these data provide evidence that TRIM59 is involved in lung carcinoma growth and progression possibly through the induction of CDK6 expression and EMT process by activation of ERK pathway.  相似文献   
118.
Phosphoinositide 3‐kinase gamma (PI3Kγ) draws an increasing attention due to its link with deadly cancer, chronic inflammation and allergy. But the development of PI3Kγ selective inhibitors is still a challenging endeavor because of the high sequence homology with the other PI3K isoforms. In order to acquire valuable information about the interaction mechanism between potent inhibitors and PI3Kγ, a series of PI3Kγ isoform‐selective inhibitors were analyzed by a systematic computational method, combining 3D‐QSAR, molecular docking, molecular dynamic (MD) simulations, free energy calculations and decomposition. The general structure–activity relationships were revealed and some key residues relating to selectivity and high activity were highlighted. It provides precious guidance for rational virtual screening, modification and design of selective PI3Kγ inhibitors. Finally, ten novel inhibitors were optimized and P10 showed satisfactory predicted bioactivity, demonstrating the feasibility to develop potent PI3Kγ inhibitors through this computational modeling and optimization.  相似文献   
119.
咸洋  董昕  解孝满 《植物学报》2019,54(1):64-71
该文主要探讨了光照时间、光照强度、温度及昼夜温差等保存条件对卓越红花槭(Acer rubrum cv. ‘Somerset’)限制生长保存的影响。结果表明, 在为期182天的保存过程中, 离体材料前期以分化生长为主, 后期以营养生长为主, 并呈现一定的低温适应性。温度对离体材料生长的影响达极显著水平(P<0.01); 光照时间和光照强度影响持久, 二者交互作用达显著水平(P<0.05); 昼夜温差对平均出芽数和生根率都有显著影响。研究表明, 保存效果最好的条件是T3 (25°C, 12小时光照, 62.50 μmol·m -2·s -1)和T7 (25°C, 12小时光照, 31.25 μmol·m -2·s -1)处理组, 但最佳保存条件的选择标准并不唯一, 其核心是保证种质材料的分化能力。  相似文献   
120.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号